30
Participants
Start Date
January 1, 2021
Primary Completion Date
December 30, 2023
Study Completion Date
December 30, 2024
CNCT19
2×10\^6/kg, infused in a single-dose on day +2, +3 or +4 following stem-cell infusion
Gemcitabine Injection
600mg/m2/h, infused for 3 hours with loading bolus of 75mg/m2, day -7, -3,
busulfan
105mg/m2, day -7 until -5,
Melphalan Injection
60mg/m2, day -3, -2
Institute of Hematology & Blood Diseases Hospital, Tianjin
Collaborators (1)
Juventas Cell Therapy Ltd.
INDUSTRY
Institute of Hematology & Blood Diseases Hospital, China
OTHER